Market News / Story
AlzeCure Pharma to present at Redeye Neurology Day on October 15
MFN by Modular Finance ·
MFN by Modular Finance reports: AlzeCure Pharma AB (publ) (FN STO: ALZCUR), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer’s disease and pain, today announced that the company will participate at Redeye Neurology Day on October 15, where CEO Martin Jönsson will present the company's development projects in neurology and provide an update on the recently signed agreements with Eli Lilly and QuantumCell. Neurology Day is Redeye's annual event on drug…